Jack Taunton PhD

Jack Taunton obtained his Ph.D. in chemistry from Harvard University. After a postdoctoral fellowship at Harvard Medical School, Jack joined the faculty of the University of California, San Francisco, where he is currently a Professor in the Department of Cellular and Molecular Pharmacology. His research focuses on the structure-based design of covalent inhibitors, as well as mechanistic studies of biologically active natural products. Jack has been named an Alfred P. Sloan Fellow, a Searle Scholar, and a Howard Hughes Medical Institute investigator. Jack is a co-founder of Principia BioPharma, Global Blood Therapeutics, and Kezar Life Sciences.